Membrane transport of andrographolide in artificial membrane and rat small intestine

Pakistan Journal of Biological Sciences

Volumn 10, Issue 12, 2007, Pages 2078-2085

  Daodee, Supawadee ^a   Wangboonskul, Jinda ^a   Jarukamjorn, Kanokwan ^a   Sripanidkulchai, Bung Orn ^a   Murakami, Teruo ^b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

Andrographolide; Drug interaction; Membrane transport; MRP2; p glycoprotein; Rat small intestine

Indexed keywords

RATTUS;

EID: 34447335840     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2007.2078.2085     Document Type: Article

References (46)

1. Anonymous, 1999. Standard of Thai herbal medicine: Andrographis paniculata (Burm.f.) Nees. Thailand: The War Veterans Organization Press.
2. Bermejo, M., A. Avdeef, A. Ruiz, R. Nalda, J.A. Ruell, O. Tsinman et al., 2004. AMPA-a drug absorption in vitro model. Eur. J. Pharm. Sci., 21: 429-441.
3. Budavari, S., 1996. The Merck Index. 12th Edn. United State of America: Merck and Co Inc.
4. Caceres, D.D., J.L. Hancke and R.A. Burgos, 1995. Double blind study with a new monodrug Kan Jang: Decrease of symptoms and improvement in the recovery from common colds. Phytother. Res., 9: 559-562.
5. Caceres, D.D., J.L. Hancke, R.A. Burgos and G.K. Wikman, 1997. Prevention of common colds with Andrographis paniculata dried extract: A pilot double blind study. Phytomedicine, 4: 101-104.
6. Chan, L.M.S., S. Lowes and B.H. Hirst, 2004. The ABCs of drug transport in intestine and liver: Efflux proteins limiting drug absorption and bioavailability. Eur. J. Pharm. Sci., 21: 25-51.
7. Chang, J.Y., C.Y. Chang, C.C. Kuo, L.T. Chen, Y.S. Wein and Y.H. Kuo, 2004. Salvinal, a novel microtubule inhibitor isolated from salvia miltiorrhizae Bunge (Danshen), with antimitotic activity in multidrug-sensitive and -resistant human tumor cells. Mol. Pharmacol., 65: 77-84.
8. Chearwae, W., S. Anuchapreeda, K. Nandigama, S.V. Ambudkar and P. Limtrakul, 2004. Biochemical mechanism of modulation of human P-glycoprotein (ABCB1) by curcumin I, II and III purified from Turmeric powder. Biochem. Pharmacol., 68: 2043-2052.
9. Dantzig, A.H., K.L. Law, J. Cao and J.J. Starling, 2001. Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic. Curr. Med. Chem., 8: 39-50.
10. Ferreira, M.J., N. Gyemant, A.M. Madureira and J. Molnar, 2005a. Inhibition of P-glycoprotein transport activity in a resistant mouse lymphoma cell line by di terpen ic lactones. Anticancer Res., 25: 3259-3262.
11. Ferreira, M.J., N. Gyemant, A.M. Madureira, M. Tanaka, K. Koos, R. Didziapetris and J. Molnar, 2005b. The effects of jatrophane derivatives on the reversion of MDR1- and MRP-mediated multidrug resistance in the MDA-MB-231 (HTB-26) cell line. Anticancer Res., 25: 4173-4178.
12. Ghanam, C.I., P.C. Gomez, M.C. Arana, M. Perassolo, M.L. Ruiz, S.S.M. Villanueva et al., 2004. Effect of acetaminophen on expression and activity of rat liver multidrug resistance-associated protein 2 and P-glycoprotein. Biochem. Pharmacol, 68: 791-798.
13. Goon, D. and C.D. Klaassen, 1990. Dose-dependent intestinal glucuronidation and sulfation of acetaminophene in the rat in situ. J. Pharmacol. Exp. Ther., 252: 201-207.
14. Gupta, P.P., J.S. Tandon and G.K. Patnaik, 1998. Antiallergic activity of andrographolides isolated from Andrographis paniculata (Burm. F) Wall. Pharm Biol., 36: 72-74.
15. He, X., M. Sugawara, M. Kobayashi, Y. Takekuma and K. Miyazaki, 2003. An in vitro system for prediction of oral absorption of relatively water-soluble drugs and ester prodrugs. Int. J. Pharm., 263: 35-44.
16. Hiep, B.T., C. Fernandez, M. Tod, H. Banide, A. Thuillier, B. Lacour, R. Farinotti and F. Gimenez.,2001. Intestinal absorption and metabolism of chlorpheniramine enantiomers in rats. Chirality, 13: 207-213.
17. Honda, Y., F. Ushigome, N. Koyabu, S. Morimoto, Y. Shoyama, T. Uchiumi, M. Kuwano, H. Ohtani and Y. Sawada, 2004. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux. Br. J. Pharmacol., 143: 856-864.
18. Horikawa, M., Y. Kato and Y. Sugiyama, 2002. Reduced gastrointestinal toxicity following inhibition of the biliary excretion of irinotecan and its metabolites by probenecid in rats. Pharm. Res., 19: 1345-1353.
19. Hunter, J., B.H. Hirst and N.L. Simmons, 1993. Drug absorption limited by P-glycoprotein-mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers. Pharm. Res., 10: 743-749.
20. Huisman, M.T., A.A. Chhatta, O.V. Tellingen, J.H. Beijnen and A.H. Schinkel, 2005. MRP2 (ABCC2) transports taxanes and confers paclitaxel resistance and both processes are stimulated by probenecid. Int. J. Cancer., 116: 824-829.
21. Imanidis, G., K.C. Hartner and N.A. Mazer, 1995. Intestinal permeation and metabolism of a model peptide (leuprolide) and mechanisms of permeation enhancement by non-ionic surfactants. Int. J. Pharm., 120: 41-50.
22. Jonker, C., J.H. Hamman and A.F. Kotze, 2002. Intestinal paracellular permeation enhancement with quaternised chitosan: In situ and in vitro evaluation. Int. J. Pharm., 238: 205-213.
23. Katherine, M.D., 2002. The mechanism of aspirin absorption in the Caco-2 model of intestinal mucosa Ph.D. Thesis in Pharmaceutical Science and Cell Biology/Biophysics. USA: University of Missouri-Kansas City.
24. Kandimalla, K.K. and M.D. Donovan, 2005. Transport of hydroxyzine and triprolidine across bovine olfactory mucosa: Role of passive diffusion in the direct nose-to-brain uptake of small molecules. Int. J. Pharm., 302: 133-144.
25. Kulichenko, L.L., L.V. Kireyeva, E.N. Malyshkina and G. Wikman, 2003. A randomized, controlled study of Kan Jang versus amantadine in the treatment of influenza in Volgograd. J. Herb. Pharm. Ther., 3: 77-93.
26. Kumar, R.A., K. Sridevi, N.V. Kumar, S. Nanduri and S. Rajagopal, 2004. Anticancer and immunostimulatory compounds from Andrographis paniculata. J. Ethnopharm., 92: 291-295.
27. Legen, I., S. Zakelj and A. Kristl, 2003. Polarised transport of monocarboxylic acid type drugs across rat jejunum in vitro: The effect of mucolysis and ATP-depletion. Int. J. Pharm., 256: 161-166.
28. Lennernas, H., L. Knutson, T. Knutson, A. Hussain, L. Lesko and T. Salmonson et al., 2002. The effect of amiloride on the in vivo effective transport of amoxycillin in human jejunum: Experience from a regional perfusion technique. Eur. J. Pharm. Sci., 15: 271-277.
29. Madav, S., S.K. Tandan, J. Lal and H.C. Tripathi, 1996. Anti-inflammatory activity of andrographolide. Fitotherapia, 67: 452-458.
30. Melchior, J., S. Palm and G. Wikman, 1996. Controlled clinical study of standaedized Andrographis paniculata extract in common cold a pilot trial. Phytomedicine, 3: 315-318.
31. Melchior, J., A.A. Spasov, O.V. Ostrovskij, A.E. Bulanov and G. Wikman, 2000. Double-blind, placebo-controlled pilot and phase HI study of activity of standardized Andrographis paniculata fixed combination Kan Jung in rats and human. Phytomedicine, 7: 341-364.
32. Naruhashi, K., I. Tamai, N. Inoue, H. Muraoka, Y. Sai, N. Suzuki and A. Tsuji, 2002. Involvement of multidrug resistance-associated protein 2 in intestinal secretion of grepafloxacin in rats. Antimicrob. Agents Chemother., 46: 344-349.
33. Netsch, M.I., H. Gutmann, S. Luescher, S. Brill, C.B. Schmidlin, M.H. Kreuter and J. Drewe, 2005. Inhibitory activity of a green tea extract and some of its constituents on multidrug resistance-associated protein 2 functionality. Planta Med., 71: 135-141.
34. Panchagnula, R., T. Bansal, M.V. Varma and C.L. Kaul, 2005. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux. Pharmazie, 60: 922-927.
35. Schaiquevich, P., N. Viviana, T. Omar and R. Modesto, 2004. Evaluation of acetaminophen P-glycoprotein-mediated salivary secretion by rat submandibular glands. Arch. Oral. Biol., 49: 895-901.
36. Shannon, M.T., B.A. Wilson and C.L. Stang, 2001. Health Professional's Drug Guide. USA: Prentice-Hall Inc. 5, 68, 99, 300, 1010.
37. Sharma, A., K. Lal and S.S. Handa, 1992. Standardization of Indian crude drug Kalmegh by high pressure liquid chromatographic determination of andrographolide. Phytochem. Anal., 3: 129.
38. Singh, Y.N., 2005. Potential for interaction of kava and St. John's wort with drugs. Ethnopharmacology, 100: 108-113.
39. Spasov, A.A., O.V. Ostrovskij, M.V. Chernikov and G. Wikman, 2004. Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in children. Phytother. Res., 18: 47-53.
40. Sriram, R., R.A. Kumar, D.S. Deevi, C. Satyanarayana and R. Rajagopalan, 2003. Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculata. J. Exp. Ther. Onc., 3: 147.
41. Suzuki, H. and Y. Sugiyama, 2002. Single nucleotide polymorphisms in multidrug resistance associated protein 2 (MRP2/ABCC2): Its impact on drug disposition. Adv. Drug Deliv. Rev., 54: 1311-1331.
42. Takano, M., R. Yumoto and T. Murakami, 2006. Expression and function of efflux drug transporters in the intestine. Pharmacol. Therap., 109: 137-161.
43. Terao, T., E. Hisanaga, Y. Sai, I. Tamai and A.Tsuji, 1996 Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. J. Pharm Pharmacol., 48: 1083-1089.
44. Vaclavikova, R., A. Boumendjel, M. Ehrlichova, J. Kovar and I. Gut, 2006. Modulation of paclitaxel transport by flavonoid derivatives in human breast cancer cells. Is there a correlation between binding affinity to NBD of P-gp and modulation of transport? Bioorg. Med. Chem., 14: 4519-4525.
45. Wang, Y., J. Cao and S. Zeng, 2005. Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: Quercetin, kaempferol and isorhamnetin. J. Pharm. Pharmacol., 57: 751-758.
46. Yumoto, R., T. Murakami, Y. Nakamoto, R. Hasegawa, J. Nagai and M. Takano, 1999. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds. J. Pharmacol. Exp. Ther., 289: 149-155.